Literature DB >> 7024325

Yersinia enterocolitica: its isolation by cold enrichment from patients and healthy subjects.

R Van Noyen, J Vandepitte, G Wauters, R Selderslaghs.   

Abstract

Routine culture and cold enrichment were compared in a prospective study on the isolation of Yersinia enterocolitica from patients with intestinal disease. Healthy controls were examined with the cold enrichment method only. Y enterocolitica was isolated from 5.9% of 1635 patient stools, 3.4% of 206 appendices, and 4.0% of 555 control stools. Serotypes 0:3 and 0:9 were eight times more prevalent in patients than in controls. Other serotypes were twice as prevalent in controls than in patients. Cold enrichment did not significantly increase the recovery of serotypes 0:3 and 0:9 in acute enteritis, but it was responsible for all isolates of the other serotypes. Evidence is presented that the other serotypes are not pathogenic. In patient stools, Y enterocolitica was demonstrated less frequently than Salmonella (9.1%), and more often than Campylobacter jejuni (1.8%) and Shigella (0.1%).

Entities:  

Mesh:

Year:  1981        PMID: 7024325      PMCID: PMC494242          DOI: 10.1136/jcp.34.9.1052

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Isolation of campylobacters.

Authors:  N A Simmons
Journal:  Br Med J       Date:  1977-09-10

2.  Human yersiniosis in Finland. I. Bacteriology and serology.

Authors:  P Ahvonen
Journal:  Ann Clin Res       Date:  1972-02

3.  Speciation in Yersinia.

Authors:  D J Brenner
Journal:  Contrib Microbiol Immunol       Date:  1979

4.  Nonvalue of cold enrichment of stools for isolation of Yersinia enterocolitica serotypes 3 and 9 from patients.

Authors:  R Van Noyen; J Vandepitte; G Wauters
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

5.  Yersinia enterocolitica in adults with gastrointestinal disturbances: need for cold enrichment.

Authors:  A S Weissfeld; A C Sonnenwirth
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

6.  Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools.

Authors:  C H Pai; S Sorger; L Lafleur; L Lackman; M I Marks
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

  6 in total
  14 in total

1.  Current evidence for human yersiniosis in Ireland.

Authors:  T Ringwood; B P Murphy; N Drummond; J F Buckley; A P Coveney; H P Redmond; J P Power; S Fanning; M B Prentice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

Review 2.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  The prevalence of Yersinia enterocolitica 0:3 in Finnish pigs and pork.

Authors:  K Asplund; V Tuovinen; P Veijalainen; J Hirn
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

4.  Etiology of traveller's diarrhea in Spanish travellers to developing countries.

Authors:  J Gascon; J Vila; M E Valls; L Ruiz; J Vidal; M Corachán; G Prats; M T Jimenez de Anta
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

5.  Yersinia and chronic glomerulopathy in the savannah region of Nigeria.

Authors:  J Vandepitte; G Wauters
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

6.  Faecal carriage rate of Yersinia species.

Authors:  A M Lewis; B Chattopadhyay
Journal:  J Hyg (Lond)       Date:  1986-10

7.  Yersinia enterocolitica and Y. enterocolitica-like species in clinical stool specimens of humans: identification and prevalence of bio/serotypes in Finland.

Authors:  L M Sihvonen; K Haukka; M Kuusi; M J Virtanen; A Siitonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-14       Impact factor: 3.267

8.  Lack of efficacy of alkali treatment for isolation of Yersinia enterocolitica from feces.

Authors:  S Ratnam; C L Looi; T R Patel
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

9.  Pyrazinamidase activity in Yersinia enterocolitica and related organisms.

Authors:  K Kandolo; G Wauters
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

10.  Clinical features of patients with novel Yersinia species.

Authors:  Conor G Loftus; Gavin C Harewood; Franklin R Cockerill; Joseph A Murray
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.